Effect of Food on the Bioavailability of Prednisone
dc.contributor.author | Tembo, Aubrey V. | en_US |
dc.contributor.author | Sakmar, Ermelinda | en_US |
dc.contributor.author | Hallmark, Margarette R. | en_US |
dc.contributor.author | Weidler, Donald J. | en_US |
dc.contributor.author | Wagner, John G. | en_US |
dc.date.accessioned | 2013-04-08T20:50:13Z | |
dc.date.available | 2013-04-08T20:50:13Z | |
dc.date.issued | 1976-11-12 | en_US |
dc.identifier.citation | Tembo, Aubrey V. ; Sakmar, Ermelinda ; Hallmark, Margarette R. ; Weidler, Donald J. ; Wagner, John G. (1976). "Effect of Food on the Bioavailability of Prednisone." The Journal of Clinical Pharmacology 16(11). <http://hdl.handle.net/2027.42/97294> | en_US |
dc.identifier.issn | 0091-2700 | en_US |
dc.identifier.issn | 1552-4604 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/97294 | |
dc.publisher | Wiley Periodicals, Inc. | en_US |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.title | Effect of Food on the Bioavailability of Prednisone | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Pharmacy and Pharmacology | en_US |
dc.subject.hlbsecondlevel | Pediatrics | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | College of Pharmacy and the Upjohn Center for Clinical Pharmacology, The University of Michigan, Ann Arbor, Mich. 48109. | en_US |
dc.identifier.pmid | 791973 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/97294/1/j.1552-4604.1976.tb01500.x.pdf | |
dc.identifier.doi | 10.1002/j.1552-4604.1976.tb01500.x | en_US |
dc.identifier.source | The Journal of Clinical Pharmacology | en_US |
dc.identifier.citedreference | Campagna, F. A., Cureton, G., Mirigian, R. A., and Nelson, E.: Inactive prednisone tablets USP XVI. J. Pharm. Sci. 52: 605 ( 1968 ). | en_US |
dc.identifier.citedreference | Levy, G., Hall, N. A., and Nelson, E.: Studies on inactive prednisone tablets USP XVI. Amer. J. Hosp. Pharm. 21: 402 ( 1964 ). | en_US |
dc.identifier.citedreference | Wagner, J. G.: Bioavailability and generic equivalency. In The Scientific Evaluation of Drug Equivalency, Proceedings of a Colloquium, Washington, D.C., June 14, 1974, Excerpta Medica, pp. 79 – 86. | en_US |
dc.identifier.citedreference | Sullivan, T. J., Sakmar, E., Albert, K. S., Blair, D. C., and Wagner, J. G.: In vitro and in vivo availability of commercial prednisone tablets. J. Pharm. Sci. 64: 1723 ( 1975 ). | en_US |
dc.identifier.citedreference | Sullivan, T. J., Sakmar, E., and Wagner, J. G.: Comparative bioavailability: a new type of in vitro—in vivo correlation exemplified by prednisone. J. Pharmacokin. Biopharm. 4: 173 ( 1976 ). | en_US |
dc.identifier.citedreference | Sullivan, T. J., Hallmark, M. R., Sakmar, E., Weidler, D. J., and Wagner, J. G.: Comparative bioavailability: eight commercial prednisone tablets. J. Pharmacokin. Biopharm. 4: 157 ( 1976 ). | en_US |
dc.identifier.citedreference | An annotated list of drugs with potential for therapeutic inequivalence based on current evidence of drug product bioavailability inequivalence. J. Amer. Pharm. Assoc. NS 13: 279 ( 1972 ). | en_US |
dc.identifier.citedreference | DiSanto, A. R., and DeSante, K. A.: Bioavailability and pharmacokinetics of prednisone in humans. J. Pharm. Sci. 64: 109 ( 1975 ). | en_US |
dc.identifier.citedreference | Wagner, J. G.: Fundamentals of Clinical Pharmacokinetics. Hamilton, Ill., Drug Intelligence Publication, 1975, p. 393. | en_US |
dc.identifier.citedreference | Bates, T. K., Sequeira, J. A., and Tembo, A. V.: Effect of food on nitrofurantoin absorption. Clin. Pharmacol. Therap. 16: 63 ( 1974 ). | en_US |
dc.identifier.citedreference | Levy, G., and Jusko, W. J.: Factors affecting the absorption of riboflavin in man. J. Pharm. Sci. 55: 285 ( 1966 ). | en_US |
dc.identifier.citedreference | Crounse, R. G.: Effective use of griseofulvin. Arch. Dermatol. 87: 176 ( 1963 ). | en_US |
dc.identifier.citedreference | Sullivan, T. J., Stoll, R. G., Sakmar, E., Blair, D. C., and Wagner, J. G.: In vitro and in vivo availability of some commercial prednisolone tablets. J. Pharmacokin. Biopharm. 2: 29 ( 1974 ). | en_US |
dc.identifier.citedreference | Colburn, W. A., and Buller, R. H.: Radioimmunoassay for prednisolone. Steroids 21: 833 ( 1973 ). | en_US |
dc.identifier.citedreference | Tembo, A. V., Schork, A. M., and Wagner, J. G.: Statistical survey of saturation analysis calibration curve data for prednisolone, prednisone and digoxin. Steroids, In press. | en_US |
dc.identifier.citedreference | Tukey, J. W.: Comparing individual means in the analysis of variance. Biometrics 5: 99 ( 1949 ). | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.